4SC AG
Biopharmaceutical company with no products under development or operational business.
VSC | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C40
- LEI:
- 391200QOKN7LGVP0RQ86
- Country:
- Germany
- Address:
- Fraunhoferstr. 22, 82152 Planegg
- Website:
- https://www.4sc.com/
- Sector:
- Manufacturing
Description
4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2019-08-28 07:30 |
4SC AG: 8 upcoming conferences
|
English | HTML • 9.9 KB | ||
| 2019-08-14 00:00 |
Half-yearly financial report 2019
|
English | PDF • 415.5 KB | ||
| 2019-08-13 07:30 |
4SC AG receives milestone payment from Link Health - Link Health initiates Phas…
|
English | HTML • 10.9 KB | ||
| 2019-08-08 07:30 |
4SC AG provides Q2 and H1 2019 update
|
English | HTML • 19.4 KB | ||
| 2019-08-01 07:30 |
4SC AG: Conference call to be hosted on 8 August 2019 to present the half-year …
|
English | HTML • 9.5 KB | ||
| 2019-07-25 07:30 |
4SC AG: Positive safety review of Phase Ib/II EMERGE study of domatinostat + av…
|
English | HTML • 13.7 KB | ||
| 2019-07-11 07:30 |
4SC AG: Positive safety review of Phase Ib/II SENSITIZE study of domatinostat +…
|
English | HTML • 13.9 KB | ||
| 2019-07-02 11:09 |
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | HTML • 4.3 KB | ||
| 2019-06-28 17:22 |
4SC AG secures EUR 11 million from capital increase
|
English | HTML • 16.9 KB | ||
| 2019-06-21 09:37 |
4SC AG announces subscription price for new shares from current capital increase
|
English | HTML • 19.4 KB | ||
| 2019-06-11 09:31 |
4SC AG resolves to issue new shares to continue to advance its drug development…
|
English | HTML • 22.9 KB | ||
| 2019-05-16 07:30 |
4SC AG: 4 upcoming conferences
|
English | HTML • 8.9 KB | ||
| 2019-04-18 07:30 |
4SC provides Q1 2019 update
|
English | HTML • 11.8 KB | ||
| 2019-04-18 00:00 |
Q1 statement / Q1 financial report 2019
|
English | PDF • 200.9 KB | ||
| 2019-04-12 15:03 |
4SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.05.2019 in Pl…
|
German | HTML • 173.1 KB |
Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 4SC AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 4SC AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
